Multi‑omics services for immunology R&D.

Decipher immune complexity to accelerate immunology & inflammation research.

Immune‑mediated diseases are driven by highly dynamic biological processes. Across autoimmune, inflammatory, and immune‑dysregulated conditions, patients with similar diagnoses, genetics, or clinical lab values often exhibit fundamentally different immune states, disease trajectories, and therapeutic responses.

Sapient’s multi‑omics services for immunology are designed to resolve this complexity. By integrating proteomic, cytokine, metabolomic, and lipidomic profiling with clinical context, we enable a systems‑level view of immune biology – revealing functional mechanisms and dynamic biomarkers.

Key questions we can answer to progress immunology pipelines:

What immune pathways are actively driving disease in patients?

How do metabolic and inflammatory pathways shape immune states?

Why do individuals with similar diagnoses respond differently to the same therapy?

How does immune biology change dynamically over time in response to exposures?

Biomarker discovery & validation.

Discover immune biomarkers associated with disease activity and progression by measuring dynamic proteins, metabolites, and lipids linked to immune response and inflammation.

Biomarkers to predict disease & drug response.

Identify biomarkers that read out treatment response and mechanism of action, enabling early detection of subtle molecular changes that precede clinical disease or follow therapeutic intervention.

Disease subtyping for patient stratification.

Uncover biologically distinct immune subtypes by integrating molecular profiles with clinical and phenotypic features – for stratification rooted in functional biology and improved with multi-biomarker signatures.

Mechanistic insights to map response & resistance.

Interrogate how therapies modulate immune pathways by tracking changes across proteomic, cytokine, and metabolic layers – supporting mechanism‑driven development for confident translation.
multi-omics services for immunology research

Comprehensive multi-omics services for immunology research, powered by next-gen approaches.

We’ve innovated our methods to profile the dynamic biology of immune-mediated diseases at a new depth and scale, capturing proteins, metabolites, and lipids that change with inflammatory and autoimmune conditions and treatments. These offerings include:

Immunology Webinar

Dynamic Biomarkers for Deep Immune Phenotyping in Autoimmune Disease

See how Sapient’s mass spectrometry-based methods can be applied to read out early and subtle changes in immune cell populations, their activation and function, and dynamic response in the setting of autoimmune disease and treatment.

Validate immune biology insights with DynamiQ™.

DynamiQ is Sapient’s longitudinal molecular‑clinical data resource, built from tens of thousands of deeply phenotyped human samples. For immunology programs, DynamiQ enables:

  • Cross‑validation of immune targets and biomarkers identified in discovery studies in independent cohorts – including patients with IBD, rheumatoid arthritis, and systemic inflammation
  • Biological contextualization of findings within and across diseases, treatments, and patient subgroups
  • Exploration of associations between observed molecular immune signatures and clinical outcomes
dynamiq contextualize metabolomics

Resolve distinct immune states within shared diagnoses via deep phenotyping.

dynamiq disease trajectories

Layer your data and ours to orthogonally validate findings and extend discoveries.

metabolomics dynamiq expansion

Anchor discoveries in real-world patient data to build confidence for translation.

How are Sapient's multi-omics services advancing immunology pipelines?

metabolomics research

What Discovery Metabolomics Reveals About Human Biology

immune response to glp-1 therapy

Systematic Inflammatory Profiling Reveals Immune Modulation in Response to Weight Loss Intervention

omics data analysis

Bioanalysis Zone Feature: Scaling biomarker discovery—more data, deeper insights

saliva proteomics

The Omics Brief | Beyond Blood: How Saliva Protein Assays are Driving Decentralized Clinical Trials

dark proteome services

Illuminating the Dark Proteome

inflammation panel absolute quantification

NULISAseq™ Inflammation Panel AQ

pah biomarkers oxysterols bile acids

Lysosomal dysfunction and inflammatory sterol metabolism in pulmonary arterial hypertension

inflammation panel inflammatory markers

NULISAseq™ Inflammation Panel 250

multiomics biomarkers

GEN Feature: “Multiomics Couples Data Generation and Clinical Science”

immune phenotyping autoimmune disease biomarkers

How deep immune phenotyping via small molecule biomarkers could change the way we diagnose and treat autoimmune diseases

immunotherapy biomarkers to predict autoimmunity

Discovery of Biomarker to Predict Immunotherapy Related Autoimmunity

Ready to discover more?

Connect with our scientists to learn how we can support development of safer, more efficacious treatments that target the underlying pathways of autoimmune & inflammatory diseases.

multi-omics drug development CRO lab